Catapult Venture Managers announced today that it has invested £500,000 into Bedforshire-based Probe Scientific as part of a £1m funding round.

Catapult Venture Managers has invested £500,000 into Probe Scientific as part of a £1m funding round.

Probe Scientific is developing disposable blood sampling products to solve clinical problems and improve healthcare.

The Bedforshire-based company is said to have a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range.

MicroEye, Probe’s first product, allows for continuous, automated and real-time sampling without removing blood from the patient.

The device incorporates a semi-permeable membrane, which sits in the vein of a patient, and a biosensor located outside the body to measure blood characteristics such as glucose, potassium and urea levels.